The quest to unravel the enigmatic origins of SARS-CoV-2—the insidious virus that precipitated the global pandemic—has led the scientific community down a path less trodden, unexpectedly alighting on an unforeseen contender: the raccoon dog. Research endeavours conducted in the early months of 2023 hint at the intriguing possibility that these East Asian creatures might serve as an intermediate host for the virus before its fateful leap into human populations.
Evidence accumulated in this line of inquiry reveals a curious phenomenon. Raccoon dogs, frequently bred for their fur within the borders of China, exhibit an unsettling capability to harbor SARS-CoV-2 whilst presenting no discernible symptoms. This silent vector status could feasibly facilitate their role as unseen propagators of the virus, thereby bridging the biological chasm to humanity. In addition, genomic analyses hint that a strain of the virus bearing remarkable similarity to SARS-CoV-2 may have circulated within raccoon dog populations before infiltrating the human domain. This compelling development dovetails neatly with the persisting hypothesis that posits the genesis of SARS-CoV-2 within the wildlife ecosystem. While the controversial theory suggesting a laboratory leak remains a viable contender, it is the wildlife proposition that continues to garner increasing empirical fortitude. Bats, renowned for their propensity to harbour a host of coronaviruses, some bearing close kinship to SARS-CoV-2, are frequently spotlighted as the potential progenitors of the virus. However, a consensus among scientists suggests that bats alone may not bridge the epidemiological gap. An intermediate host, a biological stepping-stone between bats and humans, may well exist, and raccoon dogs appear to fulfil this biological prerequisite. Previous probes into the potential intermediary role of pangolins yielded insufficient evidence, rendering the revelation regarding raccoon dogs a notable lead. Yet, pinpointing a likely intermediary host is but a waypoint in this investigative journey. The onus is upon the scientific community to undertake exhaustive research to solidify this potential link. Thus far, no raccoon dog farm has reported a SARS-like disease outbreak predating the human pandemic, and direct evidence of a human contracting the virus from these creatures remains elusive. More research is still required to determine the origin of SARS-CoV-2. Virologists emphasise the imperative of pursuing all plausible leads in the quest to elucidate the origins of SARS-CoV-2, while some express concerns that an undue focus on identifying an intermediate host might eclipse exploration of other essential avenues. These researchers advocate for an epistemological approach unclouded by presuppositions and resistant to precipitous conclusions derived from speculative data. Unearthing the origins of SARS-CoV-2 transcends mere attribution of culpability or demarcation of the precise path of transmission. It embodies the essence of fortifying our future pandemic preparedness and responsiveness, identifying potential threats, and laying the groundwork to avert a repetition of the ruinous impact of COVID-19. The ongoing investigation into SARS-CoV-2 has furnished critical understanding of the process by which viruses transition from animal to human hosts, knowledge that can serve as the bedrock for devising strategies to stymie such zoonotic transitions in the future. The inquiries involving raccoon dogs illuminate the intricate, yet undeniable, interconnectedness of human and environmental health, demonstrating how our interactions with wildlife, whether through hunting, farming, or trade, can dramatically influence our well-being. The interplay between human health and the health of our shared environment is inextricably intertwined. The imperative to safeguard both becomes increasingly apparent. As the quest for the origins of SARS-CoV-2 perseveres, each fresh revelation, no matter how minute, incrementally enhances our comprehension, edging us ever closer to understanding and mitigating future pandemics.
0 Comments
Olanzapine is an atypical antipsychotic medication commonly used to treat various mental health conditions, including schizophrenia, bipolar disorder, and major depressive disorder. It works by altering the levels of certain chemicals in the brain, which helps to reduce symptoms such as hallucinations, delusions, and abnormal thinking.
One of the critical features of olanzapine is that it is an "atypical" antipsychotic, meaning it has a different mechanism of action than traditional antipsychotics. Traditional antipsychotics, such as haloperidol, primarily target the neurotransmitter dopamine. Olanzapine, on the other hand, targets several neurotransmitters, including dopamine, serotonin, and acetylcholine. This multi-targeted approach is thought to make olanzapine more effective and better tolerated than traditional antipsychotics. One of the most common uses of olanzapine is in treating schizophrenia. Schizophrenia is a chronic mental disorder that affects how a person thinks, feels, and behaves. Symptoms of schizophrenia include hallucinations, delusions, abnormal thinking, and disordered speech. Olanzapine can help to reduce these symptoms and improve a person's ability to function in daily life. Olanzapine is also commonly used to treat bipolar disorder. Bipolar disorder is a condition characterized by episodes of mania and depression. Mania is a state of elevated or irritable mood, increased energy, and reduced need for sleep. Depression is a state of low mood, loss of interest in activities, and reduced energy. Olanzapine can help to reduce symptoms of mania and depression and stabilize a person's mood. In addition to its use in schizophrenia and bipolar disorder, olanzapine is sometimes used to treat major depressive disorder. Major depressive disorder is characterized by persistent sadness, hopelessness, and a loss of interest in activities. Olanzapine can help to reduce these symptoms and improve a person's overall mood. The standard dosage of olanzapine varies depending on the specific condition being treated and the individual patient. For the treatment of schizophrenia, the typical starting dose is 10 mg per day, which may be increased up to 20 mg per day. For the treatment of bipolar disorder, the usual starting dose is 5 mg per day, which may be increased up to 20 mg per To treat major depressive disorder, the typical starting dose is 2.5 mg per day, which may be increased up to 20 mg per day. It is important to note that olanzapine may cause several side effects. Some of the most common side effects include weight gain, drowsiness, and dry mouth. Olanzapine can also cause changes in blood sugar levels, which may concern people with diabetes. In addition, olanzapine may increase the risk of developing metabolic syndrome, a condition characterized by high blood pressure, high blood sugar, and excess body fat around the waist. Other side effects of olanzapine include constipation, nausea, and vomiting. Some people may also experience changes in blood pressure, which can be a concern for people with hypertension. Olanzapine can also cause changes in cholesterol and triglyceride levels, which may be a concern for people with heart disease. It is also important to note that olanzapine can cause drowsiness and impair a person's ability to drive or operate heavy machinery. It is also essential to avoid drinking alcohol while taking olanzapine, as alcohol can increase the risk of drowsiness and other side effects. Olanzapine is an atypical antipsychotic medication used to treat various mental health conditions, including schizophrenia, bipolar disorder, and major depressive disorder. It works by altering the levels of certain chemicals in the brain, which helps to reduce symptoms such as hallucinations, delusions, and abnormal thinking. The standard dosage of olanzapine varies depending on the specific condition being treated and the individual patient. However, it is crucial to be aware of the potential side effects of olanzapine, including weight gain, drowsiness, dry mouth, and changes in blood sugar and cholesterol levels. It is also essential to avoid drinking alcohol while taking olanzapine and to be aware that it may impair a person's ability to drive or operate heavy machinery. Olanzapine is an atypical antipsychotic medication that is commonly used to treat a wide range of mental health conditions, including schizophrenia, bipolar disorder, and major depressive disorder. It works by altering the levels of certain chemicals in the brain, which helps to reduce symptoms such as hallucinations, delusions, and abnormal thinking. One of the key features of olanzapine is that it is an "atypical" antipsychotic, meaning it has a different mechanism of action than traditional antipsychotics. Traditional antipsychotics, such as haloperidol, primarily target the neurotransmitter dopamine. Olanzapine, on the other hand, targets several neurotransmitters, including dopamine, serotonin, and acetylcholine. This multi-targeted approach is thought to make olanzapine more effective and better tolerated than traditional antipsychotics. One of the most common uses of olanzapine is in treating schizophrenia. Schizophrenia is a chronic mental disorder that affects how a person thinks, feels, and behaves. Symptoms of schizophrenia include hallucinations, delusions, abnormal thinking, and disordered speech. Olanzapine can help to reduce these symptoms and improve a person's ability to function in daily life. Olanzapine is also commonly used to treat bipolar disorder. Bipolar disorder is a condition characterized by episodes of mania and depression. Mania is a state of elevated or irritable mood, increased energy, and reduced need for sleep. Depression is a state of low mood, loss of interest in activities, and reduced energy. Olanzapine can help to reduce symptoms of mania and depression and stabilize a person's mood. In addition to its use in schizophrenia and bipolar disorder, olanzapine is also sometimes used to treat major depressive disorder. Major depressive disorder is a condition characterized by persistent feelings of sadness, hopelessness, and a loss of interest in activities. Olanzapine can help to reduce these symptoms and improve a person's overall mood. The standard dosage of olanzapine varies depending on the specific condition being treated and the individual patient. For the treatment of schizophrenia, the typical starting dose is 10 mg per day, which may be increased up to 20 mg per day. For the treatment of bipolar disorder, the typical starting dose is 5 mg per day, which may be increased up to 20 mg per day. For the treatment of major depressive disorder, the typical starting dose is 2.5 mg per day, which may be increased up to 20 mg per day. It is important to note that olanzapine may cause several side effects. Some of the most common side effects include weight gain, drowsiness, and dry mouth. Olanzapine can also cause changes in blood sugar levels, which may be a concern for people with diabetes. In addition, olanzapine may increase the risk of developing metabolic syndrome, a condition characterized by high blood pressure, high blood sugar, and excess body fat around the waist. Other side effects of olanzapine include constipation, nausea, and vomiting. Some people may also experience changes in blood pressure, which can be a concern for people with hypertension. Olanzapine can also cause changes in cholesterol and triglyceride levels, which may be a concern for people with heart disease. It is also important to note that olanzapine can cause drowsiness and may impair a person's ability to drive or operate heavy machinery. It is also important to avoid drinking alcohol while taking olanzapine, as alcohol can increase the risk of drowsiness and other side effects. Olanzapine is an atypical antipsychotic medication that is used to treat a wide range of mental health conditions, including schizophrenia, bipolar disorder, and major depressive disorder. It works by altering the levels of certain chemicals in the brain, which helps to reduce symptoms such as hallucinations, delusions, and abnormal thinking. The standard dosage of olanzapine varies depending on the specific condition being treated and the individual patient. However, it is crucial to be aware of the potential side effects of olanzapine, including weight gain, drowsiness, dry mouth, and changes in blood sugar and cholesterol levels. It is also important to avoid drinking alcohol while taking olanzapine and to be aware that it may impair a person's ability to drive or operate heavy machinery. Smoking is a major risk factor for various cancers, including lung, bladder, kidney, and cervical cancer. Smoking is the leading cause of preventable death worldwide and is responsible for an estimated 6 million deaths per year, with cancer being one of the leading causes of these deaths.
When a person smokes, they inhale more than 7,000 chemicals, many of which are toxic and can cause cancer. The smoke from cigarettes contains carcinogens, which are substances that can cause cancer. These carcinogens can damage DNA in cells, leading to mutations that can eventually develop into cancer. Lung cancer is the most common cancer caused by smoking and is responsible for most cancer deaths in smokers. The risk of lung cancer increases with the number of cigarettes smoked per day, and the years a person has smoked. Smokers are also at a higher risk of developing other types of cancer, such as oral, throat, oesophagus, stomach, pancreas, liver, kidney, bladder and cervix. Smoking also increases the risk of heart disease, stroke, and chronic obstructive pulmonary disease (COPD). Additionally, exposure to secondhand smoke, the smoke exhaled by a smoker and the smoke that comes from the burning end of a cigarette, can also increase the risk of cancer and other health problems in non-smokers. Quitting smoking is the best thing a person can do for their health. The risk of cancer and other smoking-related diseases decreases once a person stops smoking. After quitting, the risk of lung cancer decreases and eventually becomes similar to that of a non-smoker. The risk of other cancers also decreases, but the risk does not return to that of a non-smoker for some cancers. Smoking is a significant risk factor for cancer and other diseases. It is the leading cause of preventable death worldwide. Quitting smoking is the best way to reduce cancer risk and other smoking-related illnesses. If you are a smoker, talk to your doctor about resources and methods to help you quit. E-cigarettes and cigarettes are both products that deliver nicotine, a highly addictive substance, to the user. While they may seem similar on the surface, some key differences between the two products affect their impact on our health.
Cigarettes are traditional tobacco products made from rolled, dried tobacco leaves. They are ignited, and the user inhales the smoke. The smoke from cigarettes contains a mixture of more than 7,000 chemicals, many of which are toxic and can cause cancer. Inhaling smoke from cigarettes can cause damage to nearly every organ in the body and has been linked to various diseases, including lung cancer, heart disease, and COPD. E-cigarettes, also known as electronic cigarettes or vaping devices, are a relatively new product on the market. They do not produce smoke like traditional cigarettes. Instead, they use a battery-powered device to heat a liquid called e-liquid, which creates an aerosol the user inhales. E-cigarettes typically contain nicotine, but unlike cigarettes, the liquid in e-cigarettes can contain a variety of other chemicals, including flavourings, propylene glycol, and vegetable glycerin. One of the main concerns with e-cigarettes is their high levels of nicotine. Nicotine is highly addictive and can negatively affect the developing brain of young people. E-cigarettes have been linked to increased youth vaping and smoking, which can lead to addiction and long-term health problems. Additionally, the aerosol produced by e-cigarettes can contain harmful chemicals such as formaldehyde and acrolein, which can irritate the lungs and cause respiratory problems. Long-term use of e-cigarettes has also been linked to an increased risk of lung injury and death. It is important to note that e-cigarettes are unsafe alternatives to cigarettes and can cause serious health problems. The best way to protect your health is not to smoke or use e-cigarettes. If you smoke or use e-cigarettes, quitting is the best thing you can do for your health. Your doctor can help you with resources and methods to quit smoking. Both e-cigarettes and cigarettes are harmful to our health. E-cigarettes may be marketed as a safer alternative, but they still contain nicotine and other toxic chemicals that can cause serious health problems. The best way to protect your health is to quit smoking and not use e-cigarettes. Smoking cigarettes and e-cigarettes can have a significant impact on our health, leading to a variety of diseases and conditions.
Cigarette smoking is the leading cause of preventable death worldwide, responsible for an estimated 6 million deaths yearly. It is a major risk factor for lung cancer and other types of cancer, such as bladder, kidney, and cervical cancer. Smoking also increases the risk of heart disease, stroke, and chronic obstructive pulmonary disease (COPD). E-cigarettes, also known as electronic cigarettes or vaping devices, are a relatively new product on the market, and the long-term health effects are not yet fully understood. However, research has shown that e-cigarettes can also adversely affect health. E-cigarettes contain a heated liquid to create an aerosol, which the user inhales. This aerosol can include a variety of chemicals, including nicotine, flavourings, and other harmful substances. One of the main concerns with e-cigarettes is their high levels of nicotine. Nicotine is highly addictive and can negatively affect the developing brain of young people. E-cigarettes have been linked to increased youth vaping and smoking, which can lead to addiction and long-term health problems. Additionally, the aerosol produced by e-cigarettes can contain harmful chemicals such as formaldehyde and acrolein, which can irritate the lungs and cause respiratory problems. Long-term use of e-cigarettes has also been linked to an increased risk of lung injury and death. It is important to note that e-cigarettes are unsafe alternatives to cigarettes and can cause serious health problems. The best way to protect your health is not to smoke or use e-cigarettes. If you smoke or use e-cigarettes, quitting is the best thing you can do for your health. Your doctor can help you with resources and methods to quit smoking. In conclusion, smoking cigarettes and e-cigarettes can seriously affect our health, leading to various diseases and conditions. It is essential to be aware of the risks and to take steps to quit smoking or use e-cigarettes to protect our health. Diabetes Type 1 is a chronic condition in which the pancreas cannot produce enough insulin to regulate blood sugar levels. Insulin is a hormone that helps the body use sugar for energy. Too much sugar stays in the blood without enough insulin, leading to severe health problems.
Symptoms of Type 1 diabetes can include frequent urination, excessive thirst, extreme hunger, weight loss, fatigue, blurred vision, and irritability. These symptoms usually develop quickly over weeks or even days. Type 1 diabetes is an autoimmune disorder, which means that the body's immune system mistakenly attacks and destroys the cells in the pancreas that produce insulin. The exact cause of this autoimmune response is not fully understood, but genetics and environmental factors are thought to play a role. Diagnosis of Type 1 diabetes is made through a combination of blood tests, including a fasting blood glucose test, an oral glucose tolerance test, and an A1C test. The A1C test measures the average blood sugar level over the past 2-3 months. Treatment for Type 1 diabetes involves daily insulin injections or an insulin pump. Insulin can be taken as a long-acting or rapid-acting injection before meals. In addition to insulin therapy, people with Type 1 diabetes should regularly monitor their blood sugar levels, eat a healthy diet, and get regular physical activity. Managing Type 1 diabetes requires a significant commitment of time and effort, but with proper treatment and self-care, most people with the condition can lead healthy, productive lives. Regular check-ups with a healthcare provider, including an endocrinologist, are also essential to monitor the progression of the disease and detect any complications early. It's also important to note that there is no known cure for Type 1 diabetes, but with advances in treatments and technology, it is possible to manage the disease and maintain a good quality of life. Diabetes Type 1 is a chronic autoimmune disorder characterized by the inability of the pancreas to produce enough insulin to regulate blood sugar levels. It is diagnosed through a combination of blood tests and treated with insulin therapy, regular monitoring of blood sugar levels, and a healthy lifestyle. Regular check-ups with healthcare providers are also essential to monitor the progression of the disease and detect any complications early. Personalised medicine is an emerging field of healthcare that uses technology and artificial intelligence to tailor diagnosis and treatment to individual patients. With the rapid advancement of genetics and biometrics, personalised medicine is becoming increasingly popular and effective.
Personalised medicine considers each patient's unique genetic makeup and biometric data to provide a more accurate diagnosis and effective treatment. By analysing an individual's DNA, healthcare providers can identify genetic markers indicating a predisposition to certain diseases or a specific response to certain medications. One of the critical advantages of personalised medicine is its ability to improve the effectiveness of treatments. By identifying genetic markers that indicate a patient's response to certain drugs, healthcare providers can select the most appropriate therapy for that individual rather than using a one-size-fits-all approach. This can lead to better outcomes, fewer side effects, and reduced healthcare costs. Artificial intelligence is playing an increasingly important role in personalised medicine. Machine learning algorithms can analyse large amounts of data, such as genetic sequencing data, to identify patterns and make predictions about an individual's health. This can help healthcare providers make more accurate diagnoses and develop targeted treatment plans. One example of personalised medicine in action is in the field of cancer treatment. Healthcare providers can identify genetic mutations driving cancer growth by analysing a patient's tumour DNA. This can help them select the most appropriate treatment, such as a targeted therapy that targets the specific mutations driving cancer. Another area where personalised medicine is making a significant impact is mental health. By analysing genetic and biometric data, healthcare providers can identify biomarkers that indicate a predisposition to specific mental health conditions. This can help them select the most appropriate treatment and improve patient outcomes. Personalised medicine is an emerging field that uses technology and artificial intelligence to provide more accurate diagnoses and effective treatments. By analysing genetic and biometric data, healthcare providers can identify specific markers that indicate a patient's risk of certain diseases and their response to certain drugs. As a result, personalised medicine is becoming increasingly popular and effective and is expected to play a significant role in the future of healthcare. Type 2 diabetes is a chronic condition affecting how the body processes blood sugar (glucose). It is the most common form of diabetes, characterised by high blood sugar levels, insulin resistance, and, often, a relative lack of insulin.
Symptoms of Type 2 diabetes can include increased thirst, frequent urination, blurred vision, fatigue, and slow wound healing. These symptoms may develop gradually and may not be noticed for years. In some cases, there may be no symptoms at all. A combination of genetic and lifestyle factors causes type 2 diabetes. Being overweight or obese, having a sedentary lifestyle, and consuming a diet high in sugar and processed foods can all increase the risk of developing the condition. Additionally, certain ethnic groups, such as African Americans, Native Americans, and Hispanic Americans, have a higher risk of developing Type 2 diabetes. Diagnosis of Type 2 diabetes is typically made through blood tests, including a fasting blood glucose test, an oral glucose tolerance test, and an A1C test. The A1C test measures the average blood sugar level over the past 2-3 months. Treatment for Type 2 diabetes typically begins with lifestyle changes, including a healthy diet, regular physical activity, and weight loss. Medications like metformin and sulfonylureas may also be prescribed to help lower blood sugar levels. In some cases, insulin therapy may be necessary. Managing Type 2 diabetes requires a significant commitment of time and effort. Still, with proper treatment and self-care, most people with the condition can lead healthy, productive lives. Regular check-ups with a healthcare provider, including an endocrinologist, are also essential to monitor the progression of the disease and detect any complications early. It's important to note that Type 2 diabetes is a progressive disease. Over time, the body may produce less insulin and become less responsive to insulin. This can lead to increased blood sugar levels and complications such as heart disease, nerve damage, and kidney damage. Type 2 diabetes is a chronic condition affecting how the body processes blood sugar. A combination of genetic and lifestyle factors causes it. It is characterised by high blood sugar levels, insulin resistance, and, often, a relative lack of insulin. Treatment typically begins with lifestyle changes and may include medications and insulin therapy. Regular check-ups with healthcare providers are essential to monitor the progression of the disease and detect any complications early. Hair loss, also known as alopecia, is a common condition that affects both men and women. Genetics, hormonal changes, medical conditions, and certain medications can cause hair loss.
One of the most common causes of hair loss is androgenetic alopecia, a genetic condition affecting both men and women. This type of hair loss is caused by a combination of hormones and genetics and is characterized by a gradual thinning of the hair on the scalp. Men with androgenetic alopecia typically experience a receding hairline and thinning of the hair on the crown of the head. At the same time, women may notice a general thinning of the hair on the scalp. Hormonal changes, such as those that occur during pregnancy, menopause, and thyroid disorders, can also cause hair loss. Pregnancy-related hair loss is caused by hormonal changes that occur during pregnancy and typically resolves after the baby is born. Menopause-related hair loss is caused by a decline in estrogen levels and can be treated with hormone replacement therapy. Thyroid disorders, such as hypothyroidism, can cause hair loss and be treated with medication. Certain medical conditions, such as lupus, diabetes, and iron deficiency anaemia, can cause hair loss. Lupus is an autoimmune disorder that can cause hair loss on the scalp and other parts of the body. Diabetes can cause hair loss due to poor blood circulation to the scalp. Iron deficiency anaemia can cause hair loss due to a lack of iron in the body. Certain medications, such as blood thinners, birth control pills, and antidepressants, can also cause hair loss. These medications can cause hair loss by disrupting the normal hair growth cycle or by causing changes in hormone levels. Various factors, including genetics, hormonal changes, medical conditions, and certain medications can cause hair loss. If you are experiencing hair loss, it is important to consult a healthcare professional to determine the underlying cause and appropriate treatment options. China has experienced a surge in COVID-19 infections and deaths since a strict zero-COVID-19 policy was lifted in December. However, official data on the extent of the pandemic has been minimal. According to the Chinese government, between 8 December 2022 and 12 January 2023, there were 59,938 COVID-19-related deaths across the country. This figure, published on 15 January 2023, was the first update to its death toll since lockdown restrictions were lifted last year. However, this number may not represent the actual number of deaths as China has only recorded COVID-19 infections at hospitals and fever clinics for those with recognized symptoms. The data does not record asymptomatic cases or positive home testing kits results.
The World Health Organization (WHO) has asked for more “rapid, regular and reliable” data on hospitalization and deaths. Beijing says it has been sharing COVID-19 data in “a timely, open, and transparent manner in accordance with the law.” However, experts say that the new death toll may still not represent the actual number of deaths compared to figures from other countries. A study by Peking University estimated that as of 11 January 2023, some 64% of the population was reported to be infected with the virus. Reports suggest that hospitals in China are under growing strain from the number of cases, with long queues for clinics and patients on hospital beds in the middle of busy waiting rooms. Videos have emerged on social media throughout December, appearing to show crowded hospitals and funeral home queues. The BBC’s team in Beijing has also reported on long lines outside health clinics and a high demand for fever remedies at pharmacies. Temporary health centres and intensive care facilities across the country have been set up. China had one of the harshest anti-COVID-19 regimes in the world, known as its zero-COVID-19 policy, before lifting many of the restrictions in November. The measures included strict lockdowns even if only a handful of COVID-19 cases had been found, mass testing in places where cases were reported, and people with COVID-19 having to isolate at home or under quarantine at government facilities. Lockdowns have now been scrapped, and quarantine rules have been abolished. On 8 January 2023, China opened its borders without travel restrictions or quarantine measures for arrivals. |
AuthorDr. Aiken Dao This blog aims to offer succinct, yet thorough summaries of critical breakthroughs in the medical field. Whether you're a healthcare professional, a patient, or just fascinated by medicine, I trust you'll find this blog enlightening.
Patreon:
patreon.com/aikendao Archives
October 2023
Disclaimer: The content provided on this blog is for informational purposes only and is not intended to serve as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your qualified healthcare provider with any questions or concerns you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this blog.
Copyright © 2024 Dr. Aiken Dao. All rights reserved.
No part of this blog may be reproduced, distributed, or transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the author, except in the case of brief quotations embodied in critical reviews and certain other noncommercial uses permitted by copyright law. |